High CD8+ lymphocyte dose in the autograft predicts early absolute lymphocyte count recovery after peripheral hematopoietic stem cell transplantation

American Journal of Hematology

Volumn 84, Issue 1, 2009, Pages 21-28

  Atta, Elias Hallack ^a,d   De Azevedo, Alexandra Mello ^a   Maiolino, Angelo ^b   Coeiho, Cláudia Júlia Bruzzi Porto ^c   Sarcinelli, Silvia Maria Patiño ^a   De Alvarenga Máximo, Cláudia ^a   Marra, Vera Lúcia Neves ^a  

^a Hemorio   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d Department of Hemorio ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHYLPREDNISOLONE;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; APHERESIS; ARTICLE; AUTOGRAFT; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG MEGADOSE; FEMALE; HUMAN; LOW DRUG DOSE; LYMPHOCYTE COUNT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELOMA; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; AGED; CD8-POSITIVE T-LYMPHOCYTES; CHILD; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKAPHERESIS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 58149475687     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21314     Document Type: Article

References (28)

1. Pasquini M, Wang Z, Schneider L. Part I-CIBMTR summary slides, 2007. CIBMTR, Newsletter 2007;13:6-8.
2. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990:75:555-562.
3. Yoong Y, Porrata LF, Inwards DJ, et al. The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma. Leuk Lymphoma 2005;46:1287-1294.
4. Porrata LF, Inwards DJ, Micallef IN, et al. Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease. Br J Haematol 2002; 117:829-633.
5. Kim H, Sohn HJ, Kim S, et al. Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma. Bone Marrow Transplant 2Q06;37:1037-1042,
6. Porrata LF, Litzow MR, Tefferi A, et al. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 2002:16:1311-1318.
7. Nieto Y, Shpall EJ, McNiece IK, et al. Prognostic analysis of early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplant. Clin Cancer Res 2004:10:5076-5086.
8. Ferrandina G, Pierelli L, Perillo A, et al. Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: Clinical implications. Clin Cancer Res 2003:9:195-200.
9. Porrata LF, Gertz MA, Geyer SM, et al. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia 2004;18:1085-1092.
10. Porrata LF, Litzow MR, Inwards DJ, et al. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant 2004;33:291-298.
11. Mackall CL. T-cell immunodeficiency following cytotoxic antineoplastic therapy: A review. Stem Cells 2000:18:10-18.
12. Avigan D, Wu Z, Joyce R, et al. Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer. Bone yarrow Transplant. 2000:26:169-176.
13. Schlenke P, Sheikhzadeh S, Weber K, et al. Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2001:28:251-257.
14. Porrata LF, Gastineau DA, Padley D, et al. Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation. Leuk Lymphoma 2003;44:997-1000.
15. Curti BD, Ochoa AC, Powers GC, et al. Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer. J Clin Oncol 1998:18:2752-2760.
16. Laport GG, Levins BL, Stadtmauer EA, et al. Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation. Blood 2003;102:2004-2013.
17. Rapoport AP, Stadtmauer EA, Aqui N, et al. Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer. Nat Med 2005;11:1230-1237.
18. Meehan KR, Wu j, Bengtson E, et al. Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma. Bone Marrow Transplant 2007;39:695-703.
19. Porrata LF. Gastineau DA, Pineda A, et al. increasing the number of apheresis collections increases lymphocyte collection and affects survival after autologous stem cell transplantation for non-Hodgkin lymphoma. Blood (ASH Annual Meeting Abstracts) 2004; 104:Abstract 892.
20. Holtan SG, Porrata LF, Inwards DJ, et al. Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma. Br J Haematol 2006:133:628-633.
21. Holtan SG, Porrata LF, Micallef IN, et al. AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphoma. Clin Lymphoma Myeloma 2007;7:315-318.
22. Porter DL, June CH. T-cell reconstitution and expansion after hematopoietic stem ceil transplantation: 'T' it up! Bone Marrow Transplant 2005;35:935-942.
23. Rosinski SL, McNiece IK, Shpall EJ, et al. Prognostic analysis of pre-transplant peripheral T-cell levels in patients receiving an autologous hematopoietic progenitor-cell transplant. Bone Marrow Transplant 2005;36:425-430.
24. Dean R, Masci P. Pohlman B, et al. Dendritic cells in autologous hematopoietic stem ceil transplantation for diffuse large B-cell lymphoma: Graft content and post transplant recovery predict survival. Bone Marrow Transplant 2005:36:1049-1052.
25. Gattinoni L, Powell DJ Jr, Rosenberg SA, et al. Adoptive immunotherapy for cancer: Building on success. Nat Rev Immunol 2006;6:383-393.
26. Montagna D, Maccario R, Locatelli F, et al. Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia. Blood 2006;12:3843-3850.
27. Wrzesinski G, Paulos CM, Gattinoni L, et al. Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CDS T cells. J Clin Invest 2007;117:492-501.
28. Michallet M, Bilger K, Garban F, et al. Allogeneic hematopoietic stem-cell transplantation after nonmyeloabiative preparative regimens: Impact of pretransplantation and posttransplantation factors on outcome. J Clin Oncol 2001;19:3340-3349.